These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

110 related articles for article (PubMed ID: 11689076)

  • 41. Synthesis and antiinflammatory activity of 2,3-dihydro-1,4-benzodioxin methyl carboxylic acids.
    Vázquez MT; Rosell G; Pujol MD
    Farmaco; 1996 Mar; 51(3):215-7. PubMed ID: 8688144
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Structure-activity relationship studies of resveratrol and its analogues by the reaction kinetics of low density lipoprotein peroxidation.
    Cheng JC; Fang JG; Chen WF; Zhou B; Yang L; Liu ZL
    Bioorg Chem; 2006 Jun; 34(3):142-57. PubMed ID: 16712899
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Synthesis and alpha,beta-adrenergic blocking potency of 2,3-dihydro-1,4-benzodioxin derivatives. (II).
    Khouili M; Guillaumet G; Coudert G; Pujol MD
    Farmaco; 1996 Mar; 51(3):185-8. PubMed ID: 8688140
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Effect of lipid peroxidation products and antioxidants on the formation of probucol radical in low density lipoproteins.
    Shumaev KB; Ruuge EK; Dmitrovsky AA; Bykhovsky VYa ; Kukharchuk VV
    Biochemistry (Mosc); 1997 Jun; 62(6):657-60. PubMed ID: 9284547
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Novel 3,5-diaryl pyrazolines and pyrazole as low-density lipoprotein (LDL) oxidation inhibitor.
    Jeong TS; Kim KS; Kim JR; Cho KH; Lee S; Lee WS
    Bioorg Med Chem Lett; 2004 Jun; 14(11):2719-23. PubMed ID: 15125921
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Synthesis and evaluation of alpha,alpha'-disubstituted phenylacetate derivatives for T-type calcium channel blockers.
    Lee HK; Lee YS; Roh EJ; Rhim H; Lee JY; Shin KJ
    Bioorg Med Chem Lett; 2008 Aug; 18(15):4424-7. PubMed ID: 18625556
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Quantitative structure-activity analyses of novel hydroxyphenylurea derivatives as antioxidants.
    Nakao K; Shimizu R; Kubota H; Yasuhara M; Hashimura Y; Suzuki T; Fujita T; Ohmizu H
    Bioorg Med Chem; 1998 Jun; 6(6):849-68. PubMed ID: 9681151
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Potent inhibitory activities of hydrophobic aci-reductones (2-hydroxytetronic acid analogs) against membrane and human low-density lipoprotein oxidation.
    Mak IT; Murphy A; Hopper A; Witiak D; Ziemniak J; Weglicki WB
    Biochem Pharmacol; 1998 Jun; 55(11):1921-6. PubMed ID: 9714311
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Hybrid benzofuran-bisindole derivatives: new prototypes with promising anti-hyperlipidemic activities.
    Sashidhara KV; Modukuri RK; Sonkar R; Rao KB; Bhatia G
    Eur J Med Chem; 2013 Oct; 68():38-46. PubMed ID: 23954239
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Facile synthesis and biological evaluation of 3,3-diphenylpropanoyl piperazines as T-type calcium channel blockers.
    Choi YH; Baek du J; Seo SH; Lee JK; Pae AN; Cho YS; Min SJ
    Bioorg Med Chem Lett; 2011 Jan; 21(1):215-9. PubMed ID: 21126876
    [TBL] [Abstract][Full Text] [Related]  

  • 51. In vitro inhibition of low-density lipoprotein oxidation by a gemfibrozil metabolite.
    Kawamura M; Hase K; Miyazaki S
    Clin Chem; 1996 Apr; 42(4):644-5. PubMed ID: 8605687
    [No Abstract]   [Full Text] [Related]  

  • 52. Antioxidants decreases the intensification of low density lipoprotein in vivo peroxidation during therapy with statins.
    Lankin VZ; Tikhaze AK; Kukharchuk VV; Konovalova GG; Pisarenko OI; Kaminnyi AI; Shumaev KB; Belenkov YN
    Mol Cell Biochem; 2003 Jul; 249(1-2):129-40. PubMed ID: 12956408
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Synthesis and biological evaluation of novel T-type Ca2+ channel blockers.
    Jung HK; Doddareddy MR; Cha JH; Rhim H; Cho YS; Koh HY; Jung BY; Pae AN
    Bioorg Med Chem; 2004 Aug; 12(15):3965-70. PubMed ID: 15246072
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Structure-activity relationships of diphenylpiperazine N-type calcium channel inhibitors.
    Pajouhesh H; Feng ZP; Ding Y; Zhang L; Pajouhesh H; Morrison JL; Belardetti F; Tringham E; Simonson E; Vanderah TW; Porreca F; Zamponi GW; Mitscher LA; Snutch TP
    Bioorg Med Chem Lett; 2010 Feb; 20(4):1378-83. PubMed ID: 20117000
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Antioxidant activity of newly synthesized 2,7-diazaphenothiazines.
    Morak-Młodawska B; Pluta K; Matralis AN; Kourounakis AP
    Arch Pharm (Weinheim); 2010 May; 343(5):268-73. PubMed ID: 20232371
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Synthesis and pharmacological evaluation of some 2,3-dihydro-3-phenyl-1,4-benzodioxin derivatives.
    Salimbeni A; Manghisi E; Ferni G; Fregnan GB; Vidali M
    Farmaco Sci; 1981 Nov; 36(11):932-41. PubMed ID: 7308460
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Synthesis of novel N-(2-hydroxy-2-p-tolylethyl)-amide and N-(2-oxo-2-p-tolylethyl)-amide derivatives and their antidyslipidemic and antioxidant activity.
    Narender T; Rajendar K; Sarkar S; Singh VK; Chaturvedi U; Khanna AK; Bhatia G
    Bioorg Med Chem Lett; 2011 Nov; 21(21):6393-7. PubMed ID: 21930379
    [TBL] [Abstract][Full Text] [Related]  

  • 58. New 3-[4-(2,3-dihydro-14-benzodioxin-5-yl)piperazin-1-yl]-1-(5-substituted benzo[b]thiophen-3-yl)propanol derivatives with dual action at 5-HT(1A) serotonin receptors and serotonin transporter as a new class of antidepressants.
    Silanes SP; Orús L; Oficialdegui AM; Martínez Esparza J; Lasheras B; Del Río J; Monge A
    Pharmazie; 2004 Jul; 59(7):499-501. PubMed ID: 15296084
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Protection by Ca2+ channel blockers (nifedipine, diltiazem and verapamil) against the toxicity of oxidized low density lipoprotein to cultured lymphoid cells.
    Nègre-Salvayre A; Salvayre R
    Br J Pharmacol; 1992 Nov; 107(3):738-44. PubMed ID: 1472971
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Aspirin prodrugs: synthesis of 2-substituted 2-methyl-4H-1,3-benzodioxin-4-ones and their screening for prodrug potential.
    Nielsen KK; Senning A
    Acta Chem Scand (Cph); 1990 Oct; 44(9):952-6. PubMed ID: 2291862
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.